DSM N.V.
amsterdam : DSM

May 17, 2011 02:24 ET

DSM finalizes repurchase of shares to cover existing option plans

HEERLEN, NETHERLANDS--(Marketwire - May 17, 2011) -


Royal DSM, the global Life Sciences and Materials Sciences company, has finalized the announced program to repurchase 5,000,000 ordinary shares to cover its commitments under existing management and personnel option plans. This program was announced on 23 February 2011.

DSM repurchased 264,319 of its own shares in the period from 13 May 2011 up to and including 16 May 2011 at an average price of EUR 46.56. The consideration of this repurchase was EUR 12.3 million. With this repurchase the total number of shares repurchased under this program to date reached 5,000,000 shares for a total consideration of EUR 219.7 million. This concludes the repurchase program.

DSM - Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com

Press release-pdf: http://hugin.info/130663/R/1516402/452711.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1516402]

Contact Information

  • For more information:

    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact